Bioaffinity Technologies Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.41

-0.52 (-6.56%)

As of Sep 28, 10:46 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +283.1% upside

Low Target $22.24

Average Target $28.39

High Target $33.42

Current Price $7.41

Current
$7.41

Target
$28.39

$22.24 $28.39 avg $33.42

Scenario Analysis

Bear Case

$22.24

200.1%

Low target

Base Case

$28.39

+283.1%

Avg target

Bull Case

$33.42

+351.0%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$109.35

-93.2% from high

52-Week Low

$4.56

+62.5% from low

Target vs 52W High

$28.39

-74.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%